Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]
News [2695]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Advances in prostate cancer - Expert discussion
Prof Kurt Miller, Dr Heather Payne, Dr Maria de Santis, Prof Frédéric Lecouvet
Advances in prostate cancer - Expert discussion ( Prof Kurt Miller, Dr Heather Payne, Dr Maria de Santis, Prof Frédéric Lecouvet )
23 Jan 2015
ecancermedicalscience editor's choice for December 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for December 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Dec 2014
UICC 2014 conference report
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
UICC 2014 conference report ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Dec 2014
Combination of eribulin and capecitabine provides clinical benefit for women...
Dr Chris Twelves - St James's Hospital, Leeds, UK
Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer ( Dr Chris Twelves - St James's Hospital, Leeds, UK )
12 Dec 2014
High tumour immune cell levels may help screen HER2-positive breast cancer...
Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
12 Dec 2014
Progression-free survival results from BOLERO-1 trial
Prof Sara Hurvitz - University of California, Los Angeles, USA
Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal...
Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
11 Dec 2014
Comment: Capecitabine for elderly early-stage breast cancer
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Capecitabine for elderly early-stage breast cancer ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
11 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation